These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8542952)

  • 1. Characterization of acute bone marrow graft rejection in T cell-depleted, partially mismatched related donor bone marrow transplantation.
    Lamb LS; Szafer F; Henslee-Downey PJ; Walker M; King S; Godder K; Pati AR; Best R; Steinman L; Geier SS
    Exp Hematol; 1995 Dec; 23(14):1595-600. PubMed ID: 8542952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute rejection of marrow grafts in patients transplanted from a partially mismatched related donor: clinical and immunologic characteristics.
    Lamb LS; Gee AP; Parrish RS; Lee C; Walker M; Geier S; Harris G; Pati A; Godder K; Henslee-Downey PJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1021-7. PubMed ID: 8807109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator-responder pairs.
    Fujiwara H; Sconocchia G; Melenhorst J; Eniafe R; Nakamura R; Hensel N; Barrett AJ
    Bone Marrow Transplant; 2003 Aug; 32(4):371-8. PubMed ID: 12900773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
    Gaschet J; Lim A; Liem L; Vivien R; Hallet MM; Harousseau JL; Even J; Goulmy E; Bonneville M; Milpied N; Vié H
    J Clin Invest; 1996 Jul; 98(1):100-7. PubMed ID: 8690780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-nonself discrimination and repertoire selection of human T cells differentiated in an HLA-semiallogeneic environment following bone marrow transplantation for severe combined immunodeficiency.
    Knobloch C; Goldmann SF; Friedrich W
    Eur J Immunol; 1991 Oct; 21(10):2479-87. PubMed ID: 1833204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of self HLA-DR-specific CD3+CD4-CD8+ cytotoxic T cells in chronic graft-versus-host disease.
    Yamamoto M; Sugihara K; Ohtsuki F; Tsujino Y; Tanaka A; Kamiya T; Wada H; Kanamaru A; Hara H; Yano A
    Bone Marrow Transplant; 1994 Oct; 14(4):525-33. PubMed ID: 7858527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.
    Kaminski E; Hows J; Man S; Brookes P; Mackinnon S; Hughes T; Avakian O; Goldman JM; Batchelor JR
    Transplantation; 1989 Oct; 48(4):608-13. PubMed ID: 2508280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease.
    Jiang YZ; Mavroudis DA; Dermime S; Molldrem J; Hensel NF; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(9):899-903. PubMed ID: 9156263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T-cell population.
    Goolsby CL; Kuchnio M; Finn WG; Peterson L
    Cytometry; 2000 Jun; 42(3):188-95. PubMed ID: 10861692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
    Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
    J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimerism studies using in situ hybridization for the Y chromosome after T cell-depleted bone marrow transplantation.
    Przepiorka D; Gonzales-Chambers R; Winkelstein A; Rosenfeld C; Shadduck RK
    Bone Marrow Transplant; 1990 Apr; 5(4):253-7. PubMed ID: 2337737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3+, 4+ and/or 8+ T cells and CD3+, 4-, 8- T cells repopulate at different rates after allogeneic bone marrow transplantation.
    Gratama JW; Fibbe WE; Visser JW; Kluin-Nelemans HC; Ginsel LA; Bolhuis RL
    Bone Marrow Transplant; 1989 May; 4(3):291-6. PubMed ID: 2543471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
    Elmaagacli AH; Becks HW; Beelen DW; Stockova J; Bützler R; Opalka B; Schaefer UW
    Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients.
    Bosserman LD; Murray C; Takvorian T; Anderson KC; Freedman AS; Fitzsimmons J; Coral F; Nadler LM; Schlossman SF; Ritz J
    Bone Marrow Transplant; 1989 May; 4(3):239-45. PubMed ID: 2659109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.